Terms: = Gastric cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
27 results:
1. Success of susceptibility-guided eradication of
Wang YM; Chen MY; Chen J; Zhang XH; Feng Y; Han YX; Li YL
World J Gastroenterol; 2024 Jan; 30(2):184-195. PubMed ID: 38312120
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology.
Li B; Miao R; Shan F; Li S; Jia Y; Xue K; Li Z; Ying X; Pang F; Zhang Y; Ji J; Li Z
World J Surg Oncol; 2023 Jul; 21(1):204. PubMed ID: 37434202
[TBL] [Abstract] [Full Text] [Related]
3. cancer survival analysis and spatial distribution during 2014-2016 in Shandong Province, China.
Jiang F; Fu Z; Lu Z; Chu J; Xu A; Guo X; Ma J
Sci Rep; 2023 Jun; 13(1):10324. PubMed ID: 37365230
[TBL] [Abstract] [Full Text] [Related]
4. S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trial.
Stocker G; Lorenzen S; Ettrich T; Herz AL; Longo F; Kiani A; Venerito M; Trojan J; Mahlberg R; Moosmann N; Chibaudel B; Kubicka S; Greil R; Daum S; Geissler M; Larcher-Senn J; Keller G; Lordick F; Haag GM
ESMO Open; 2023 Jun; 8(3):101572. PubMed ID: 37270871
[TBL] [Abstract] [Full Text] [Related]
5. Dosimetry impact of gating latency in cine magnetic resonance image guided breath-hold pancreatic cancer radiotherapy.
Hu P; Li X; Liu W; Yan B; Xue X; Yang F; Ford JC; Portelance L; Yang Y
Phys Med Biol; 2022 Feb; 67(5):. PubMed ID: 35144247
[No Abstract] [Full Text] [Related]
6. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.
Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
Int J Cancer; 2021 Jul; 149(2):287-296. PubMed ID: 33634852
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
8. Comparison of Platinum/S-1 and Platinum/5-Fluorouracil as First-Line Chemotherapy for Advanced gastric or Gastroesophageal Junction cancer: A Meta-Analysis Based on Randomized Controlled Trials.
Luo D; Wang L; Chen X; Xiong Y; Yi F; Ding J; Ding H; Wei Y; Zhang W
Chemotherapy; 2020; 65(1-2):11-20. PubMed ID: 32535588
[TBL] [Abstract] [Full Text] [Related]
9. Impact of the Neutrophil-to-Lymphocyte Ratio on the Survival of Patients with gastric cancer Treated with Nivolumab Monotherapy.
Yamada T; Hayashi T; Inokuchi Y; Hayashi K; Watanabe H; Komori K; Kano K; Shimoda Y; Fujikawa H; Shiozawa M; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Target Oncol; 2020 Jun; 15(3):317-325. PubMed ID: 32319020
[TBL] [Abstract] [Full Text] [Related]
10. Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study.
Wen F; Zheng H; Zhang P; Zhou J; Chen H; Zhou K; Li Q; Bi F
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13196. PubMed ID: 31825141
[TBL] [Abstract] [Full Text] [Related]
11. Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer.
Ryu ES; Chang SJ; An J; Yang JY; Chung JW; Kim YJ; Kim KO; Park DK; Kwon KA; Nam S; Lee WK; Kim JH
PLoS One; 2019; 14(10):e0224019. PubMed ID: 31626653
[TBL] [Abstract] [Full Text] [Related]
12. Validity of additional surgical resection by comparing the operative risk with the stratified lymph node metastatic risk in patients with early gastric cancer after endoscopic submucosal dissection.
Akaike H; Kawaguchi Y; Shiraishi K; Shimizu H; Furuya S; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Inoue S; Kohno H; Ichikawa D
World J Surg Oncol; 2019 Aug; 17(1):136. PubMed ID: 31382963
[TBL] [Abstract] [Full Text] [Related]
13. Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced gastric cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
Yoshikawa T; Muro K; Shitara K; Oh DY; Kang YK; Chung HC; Kudo T; Chin K; Kadowaki S; Hamamoto Y; Hironaka S; Yoshida K; Yen CJ; Omuro Y; Bai LY; Maeda K; Ozeki A; Yoshikawa R; Kitagawa Y
JAMA Netw Open; 2019 Aug; 2(8):e198243. PubMed ID: 31373648
[TBL] [Abstract] [Full Text] [Related]
14. The clinical outcomes of S-1 plus cisplatin for patients with advanced gastric cancer: A meta-analysis and systematic review.
Yang L; Wang X; Wang B; Chao P; Li D; Chai C
Medicine (Baltimore); 2018 Dec; 97(49):e12789. PubMed ID: 30544367
[TBL] [Abstract] [Full Text] [Related]
15. A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent gastric cancer Who Failed in First-line Therapy (KCSG ST10-01).
Lee KW; Maeng CH; Kim TY; Zang DY; Kim YH; Hwang IG; Oh SC; Chung JS; Song HS; Kim JW; Jeong SJ; Cho JY
Oncologist; 2019 Jan; 24(1):18-e24. PubMed ID: 30126861
[TBL] [Abstract] [Full Text] [Related]
16. cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract] [Full Text] [Related]
17. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F; Yang X; Wang X; Yan Q
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
[TBL] [Abstract] [Full Text] [Related]
18. Co-occurrence of second primary malignancy in patients with thyroid cancer.
Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
[TBL] [Abstract] [Full Text] [Related]
19. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract] [Full Text] [Related]
20. CT-gastrography for early gastric cancer visualized by wall-carving technique using contrast-enhanced MDCT for portal phase.
Kitano I; Noguchi T; Mizuguchi M; Nishihara M; Hara Y; Azama S; Yamaguchi K; Hirai T; Takase Y; Liu L; Noshiro H; Fujimoto K; Irie H
Fukuoka Igaku Zasshi; 2013 May; 104(5):89-98. PubMed ID: 23885393
[TBL] [Abstract] [Full Text] [Related]
[Next]
